Business
NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner ...
About this update from Neupath Health Inc.
[{"type":"text","content":"NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n.bwblockalignl { margin-left: 0px; margin-right: auto }\n.bwcellpmargin { margin-bottom: 0px; margin-top: 0px }\n.bwpadl0 { padding-left: 0px }\n.bwpadr0 { padding-right: 0px }\n.bwrowaltcolor1 { background-color: #d3d3d3 }\n.bwtablemarginb { margin-bottom: 10px }\n.bwvertalignb { vertical-align: bottom }\n.bwvertalignm { vertical-align: middle }\n.bwwidth1 { width: 1% }\n.bwwidth100 { width: 100% }\n.bwwidth18 { width: 18% }\n.bwwidth24 { width: 24% }\n \n\n\n\n NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 11, 2025 and the grant of stock options (“Options”) and restricted share units (“RSUs”). All figures are in Canadian dollars, unless otherwise noted.\n \n\n The results of the director elections were as follows:\n \n\n\n\n\n\n Name\n \n\n\n\n\n\n\n Votes in\n \n\n\n\n Favour\n \n\n\n\n\n\n\n % Votes in\n \n\n\n\n Favour\n \n\n\n\n\n\n\n Votes\n \n\n\n\n Withheld\n \n\n\n\n\n\n\n % Votes\n \n\n\n\n Withheld\n \n\n\n\n\n\n\n Jolyon Burton\n \n\n\n\n\n 15,780,716\n \n\n\n\n\n\n\n\n 99.99%\n \n\n\n\n\n\n\n\n 1,000\n \n\n\n\n\n\n\n\n 0.01%\n \n\n\n\n\n\n Daniel Chicoine\n \n\n\n\n\n 15,780,716\n \n\n\n\n\n\n\n\n 99.99%\n \n\n\n\n\n\n\n\n 1,000\n \n\n\n\n\n\n\n\n 0.01%\n \n\n\n\n\n\n Sasha Cucuz\n \n\n\n\n\n 15,775,716\n \n\n\n\n\n\n\n\n 99.96%\n \n\n\n\n\n\n\n\n 6,000\n \n\n\n\n\n\n\n\n 0.04%\n \n\n\n\n\n\n Dan Legault\n \n\n\n\n\n 15,780,716\n \n\n\n\n\n\n\n\n 99.99%\n \n\n\n\n\n\n\n\n 1,000\n \n\n\n\n\n\n\n\n 0.01%\n \n\n\n\n\n\n Joseph Walewicz\n \n\n\n\n\n 15,780,716\n \n\n\n\n\n\n\n\n 99.99%\n \n\n\n\n\n\n\n\n 1,000\n \n\n\n\n\n\n\n\n 0.01%\n \n\n\n\n\n The shareholders of the Company also voted: (i) to reappoint Ernst & Young LLP, Chartered Professional Accountants, Licensed Public Accountants, as auditors of the Company for the ensuing year, (ii) to approve the Company’s amended and restated stock option plan in the form attached as Schedule ...